| Code | Description | Claims | Bene. Records | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,196 |
1,146 |
$118K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
704 |
694 |
$102K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
662 |
647 |
$57K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
394 |
393 |
$55K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
767 |
751 |
$33K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
636 |
617 |
$17K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
114 |
111 |
$16K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
57 |
50 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
146 |
145 |
$12K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
322 |
321 |
$11K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
45 |
44 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
247 |
243 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
89 |
89 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
30 |
30 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
29 |
29 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
103 |
100 |
$2K |
| 81002 |
|
74 |
70 |
$431.23 |
| 87070 |
|
21 |
21 |
$428.41 |
| 81025 |
|
19 |
15 |
$257.35 |